Evolution and emerging future of cytoreducxtive surgery and hyperthermic intraperitoneal chemoperfusion in gastric cancer: From treating the incurable to preventing recurrence.
about
Nuclear heat shock protein 110 expression is associated with poor prognosis and hyperthermo-chemotherapy resistance in gastric cancer patients with peritoneal metastasis.HCRP1 downregulation confers poor prognosis and induces chemoresistance through regulation of EGFR-AKT pathway in human gastric cancer.Adjuvant intraperitoneal chemotherapy for the treatment of colorectal cancer at risk for peritoneal carcinomatosis: a systematic review.
P2860
Evolution and emerging future of cytoreducxtive surgery and hyperthermic intraperitoneal chemoperfusion in gastric cancer: From treating the incurable to preventing recurrence.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Evolution and emerging future ...... able to preventing recurrence.
@en
type
label
Evolution and emerging future ...... able to preventing recurrence.
@en
prefLabel
Evolution and emerging future ...... able to preventing recurrence.
@en
P2093
P2860
P50
P1476
Evolution and emerging future ...... able to preventing recurrence.
@en
P2093
Franco Roviello
Giandomenico Roviello
Lorenzo de Franco
Riccardo Piagnerelli
Roberto Petrioli
P2860
P304
P356
10.3109/02656736.2015.1111432
P577
2015-12-15T00:00:00Z